Van ECK Associates Corp purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA – Get Rating) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 1,074 shares of the company’s stock, valued at approximately $46,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Glassman Wealth Services purchased a new position in shares of Azenta during the 2nd quarter valued at $25,000. Quadrant Capital Group LLC purchased a new position in shares of Azenta during the 2nd quarter valued at $26,000. Wipfli Financial Advisors LLC purchased a new position in shares of Azenta during the 3rd quarter valued at $32,000. Castle Wealth Management LLC purchased a new position in shares of Azenta during the 2nd quarter valued at $34,000. Finally, Assetmark Inc. purchased a new position in shares of Azenta during the 2nd quarter valued at $39,000. Hedge funds and other institutional investors own 96.42% of the company’s stock.
Analysts Set New Price Targets
Several analysts have commented on the stock. Needham & Company LLC boosted their price target on shares of Azenta from $74.00 to $78.00 and gave the stock a “buy” rating in a research note on Tuesday, November 15th. Stephens boosted their price target on shares of Azenta from $60.00 to $65.00 in a research note on Thursday, November 17th. KeyCorp decreased their price target on shares of Azenta from $90.00 to $70.00 and set an “overweight” rating on the stock in a research note on Monday, October 24th. Finally, TheStreet upgraded shares of Azenta from a “d+” rating to a “c-” rating in a research note on Tuesday, December 13th. Four analysts have rated the stock with a buy rating, Based on data from MarketBeat, Azenta has a consensus rating of “Buy” and a consensus target price of $72.60.
Azenta Stock Down 1.4 %
Azenta (NASDAQ:AZTA – Get Rating) last posted its earnings results on Monday, November 14th. The company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.10. Azenta had a net margin of 383.23% and a return on equity of 1.31%. The firm had revenue of $137.57 million for the quarter, compared to the consensus estimate of $132.01 million. As a group, sell-side analysts expect that Azenta, Inc. will post 0.33 earnings per share for the current fiscal year.
Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.
- Get a free copy of the StockNews.com research report on Azenta (AZTA)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.